OPTIMIERUNG DES AMINOSÄUREZUSATZES ZU SCP (METHYLOMONAS CLARA) FÜR DIE AUFZUCHT JAPANISCHER WACHTELN (COT.COT.JAPONICA)
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Issue Date
1982Submitted date
2022-12-08
Metadata
Show full item recordAbstract
Optimizing the amino acid supplementation of SCP (methylomonas clara) in raising Japanese baby quail (cot.cot.japonica) | Several experiments with a bacterial Single Cell Protein (methylomonas clara) as the sole source of protein were conducted on day old Japanese quail using semipurified diets (corn starch, soy oil, minerals, vitamins). A mixture of soy flour and isolated soy protein (Purina RP 100) supplemented with dl-methionine and glycine served as control protein. All diets were calculated isocalorically and were fed as pellets. The trials were finished after 16 - 18 days. In experiments with 25% SCP methionine could be identified as the first limiting amino acid in SCP and arginine as the second one. Best results were obtained with a total of 4.9 sulphur amino acids and 6.1 arginine calculated as percentage of SCP amino acid protein. With 25-303 dietary SCP supplemented with methionine and arginine at the above level, growth was only slightly (2-5%) below the control level. However 50% dietary SCP resulted in growth rates of only 85 - 88% of the soy control. Inconsistent results were obtained by addition of glutamic acid to SCP diets.Citation
Mikrobielle Proteingewinnung und Biotechnologie, 2. Symposium, 1980, 175-182Affiliation
Institut für Physiologie, Physiologische Chemie und Ernährungsphysiologie, Tierärztliche Fakultät, Ludwig-Maximilians-Universität München Veterinärstr. 13, D-8000 München 22Type
Book chapterconference paper
Language
deCollections
The following license files are associated with this item:
- Creative Commons
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-ShareAlike 4.0 International